المؤلفون: Mikkelsen, Rasmus R, Hundahl, Malthe P, Torp, Christopher K, Rodríguez-Carrio, Javier, Kjolby, Mads, Bruun, Jens M, Kragstrup, Tue W

المصدر: Mikkelsen , R R , Hundahl , M P , Torp , C K , Rodríguez-Carrio , J , Kjolby , M , Bruun , J M & Kragstrup , T W 2022 , ' Immunomodulatory and immunosuppressive therapies in cardiovascular disease and type 2 diabetes mellitus : A bedside-to-bench approach ' , European Journal of Pharmacology , vol. 925 , 174998 . https://doi.org/10.1016/j.ejphar.2022.174998Test

مصطلحات موضوعية: Animals, Cardiovascular Diseases/drug therapy, Colchicine, Diabetes Mellitus, Type 2/complications, Etanercept/pharmacology, Humans, Hydroxychloroquine/therapeutic use, Immunosuppression Therapy, Inflammation/chemically induced, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Methotrexate/therapeutic use, Sulfasalazine/therapeutic use, Hydroxychloroquine/pharmacology, Immunomodulating Agents/pharmacology, Sulfasalazine/pharmacology, Colchicine/pharmacology, Interleukin-1/antagonists & inhibitors, Type 2/drug therapy, Interleukin 1 Receptor Antagonist Protein/pharmacology, Interleukin-1beta/antagonists & inhibitors, Antibodies, Monoclonal, Humanized/pharmacology, Immunosuppressive Agents/pharmacology, Inflammation/drug therapy, Methotrexate/pharmacology

وصف الملف: application/pdf

العلاقة: https://pure.au.dk/portal/da/publications/immunomodulatory-and-immunosuppressive-therapies-in-cardiovascular-disease-and-type-2-diabetes-mellitusTest(89dc7ad3-f029-46e6-b0e6-b29b06deb44c).html

الإتاحة: https://doi.org/10.1016/j.ejphar.2022.174998Test
https://pure.au.dk/portal/da/publications/immunomodulatory-and-immunosuppressive-therapies-in-cardiovascular-disease-and-type-2-diabetes-mellitusTest(89dc7ad3-f029-46e6-b0e6-b29b06deb44c).html
https://pure.au.dk/ws/files/352590179/1-s2.0-S001429992200259X-main.pdfTest

المؤلفون: Rebane, Katariina, Tuomi, Anna-Kaisa, Kautiainen, Hannu, Peltoniemi, Suvi, Glerup, Mia, Aalto, Kristiina

المصدر: Rebane , K , Tuomi , A-K , Kautiainen , H , Peltoniemi , S , Glerup , M & Aalto , K 2022 , ' Abdominal pain in Finnish young adults with juvenile idiopathic arthritis ' , Scandinavian Journal of Gastroenterology , vol. 57 , no. 10 , pp. 1189-1194 . https://doi.org/10.1080/00365521.2022.2072691Test

مصطلحات موضوعية: Abdominal Pain/etiology, Adult, Anti-Inflammatory Agents/therapeutic use, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use, Antirheumatic Agents/therapeutic use, Arthritis, Juvenile/complications, Fatigue, Female, Finland/epidemiology, Follow-Up Studies, Humans, Methotrexate/therapeutic use, Quality of Life, Sulfasalazine/therapeutic use, Young Adult, synthetic disease modifying antirheumatic drugs, outcome measures, health-related quality of life, juvenile idiopathic arthritis, young adults, Abdominal pain

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.1080/00365521.2022.2072691Test
https://pure.au.dk/portal/da/publications/abdominal-pain-in-finnish-young-adults-with-juvenile-idiopathic-arthritisTest(d97c2423-39c6-44b6-8199-996f955a81b6).html
https://pure.au.dk/ws/files/329878044/Abdominal_pain_in_Finnish_young_adults_with_juvenile_idiopathic_arthritis.pdfTest

المؤلفون: Katariina Rebane, Anna-Kaisa Tuomi, Hannu Kautiainen, Suvi Peltoniemi, Mia Glerup, Kristiina Aalto

المساهمون: HUS Children and Adolescents, Children's Hospital, University of Helsinki, HUS Inflammation Center, Reumatologian yksikkö

المصدر: Rebane, K, Tuomi, A-K, Kautiainen, H, Peltoniemi, S, Glerup, M & Aalto, K 2022, ' Abdominal pain in Finnish young adults with juvenile idiopathic arthritis ', Scandinavian Journal of Gastroenterology, vol. 57, no. 10, pp. 1189-1194 . https://doi.org/10.1080/00365521.2022.2072691Test

مصطلحات موضوعية: young adults, Adult, Abdominal pain, Methotrexate/therapeutic use, Sulfasalazine/therapeutic use, Finland/epidemiology, Anti-Inflammatory Agents, CHILDREN, Antirheumatic Agents/therapeutic use, Anti-Inflammatory Agents/therapeutic use, outcome measures, Young Adult, QUALITY-OF-LIFE, EPIDEMIOLOGY, Humans, POPULATION, Fatigue, Finland, ASSOCIATIONS, synthetic disease modifying antirheumatic drugs, RISK, Anti-Inflammatory Agents, Non-Steroidal, Gastroenterology, Arthritis, Juvenile/complications, Arthritis, Juvenile, RHEUMATOID-ARTHRITIS, PREVALENCE, Abdominal Pain, Abdominal Pain/etiology, health-related quality of life, Sulfasalazine, Methotrexate, 3121 General medicine, internal medicine and other clinical medicine, Antirheumatic Agents, juvenile idiopathic arthritis, Quality of Life, Female, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use, INFLAMMATORY-BOWEL-DISEASE, FATIGUE SEVERITY SCALE, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf5600b38f0bf70bc5fcb99d3dc2014eTest
https://doi.org/10.1080/00365521.2022.2072691Test

المؤلفون: Lukas, Cédric, Mary, Julia, Debandt, Michel, Daien, Claire, Morel, Jacques, Cantagrel, Alain, Fautrel, Bruno, Combe, Bernard

المساهمون: Département de Rhumatologie Montpellier, Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier)-Hôpital Lapeyronie, Université de Montpellier (UM), Hôpital Pierre Zobda-Quitman CHU de la Martinique, CHU de la Martinique Fort de France, Service de Rhumatologie CHU de Montpellier, CHU Montpellier, Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)

المصدر: ISSN: 1478-6354 ; Arthritis Research and Therapy ; https://hal.umontpellier.fr/hal-02542646Test ; Arthritis Research and Therapy, 2019, 21 (1), pp.243. ⟨10.1186/s13075-019-2020-x⟩.

مصطلحات موضوعية: Seronegative, Rheumatoid arthritis, DMARD, ESPOIR cohort, MESH: Anti-Citrullinated Protein Antibodies / blood, MESH: Antirheumatic Agents / therapeutic use, MESH: Immunosuppressive Agents / therapeutic use, MESH: Leflunomide / therapeutic use, MESH: Methotrexate / therapeutic use, MESH: Rheumatoid Factor / blood, MESH: Sulfasalazine / therapeutic use, MESH: Treatment Outcome, MESH: Arthritis, Rheumatoid / blood, Rheumatoid / drug therapy, Rheumatoid / pathology, MESH: Cohort Studies, MESH: Disability Evaluation, MESH: Drug Therapy, Combination, MESH: Humans, MESH: Hydroxychloroquine / therapeutic use, [SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31730497; hal-02542646; https://hal.umontpellier.fr/hal-02542646Test; https://hal.umontpellier.fr/hal-02542646/documentTest; https://hal.umontpellier.fr/hal-02542646/file/s13075-019-2020-x.pdfTest; PUBMED: 31730497; PUBMEDCENTRAL: PMC6858774

الإتاحة: https://doi.org/10.1186/s13075-019-2020-xTest
https://hal.umontpellier.fr/hal-02542646Test
https://hal.umontpellier.fr/hal-02542646/documentTest
https://hal.umontpellier.fr/hal-02542646/file/s13075-019-2020-x.pdfTest

المؤلفون: Rasmus R. Mikkelsen, Malthe P. Hundahl, Christopher K. Torp, Javier Rodríguez-Carrio, Mads Kjolby, Jens M. Bruun, Tue W. Kragstrup

المصدر: Scopus
Mikkelsen, R R, Hundahl, M P, Torp, C K, Rodríguez-Carrio, J, Kjolby, M, Bruun, J M & Kragstrup, T W 2022, ' Immunomodulatory and immunosuppressive therapies in cardiovascular disease and type 2 diabetes mellitus : A bedside-to-bench approach ', European Journal of Pharmacology, vol. 925, 174998 . https://doi.org/10.1016/j.ejphar.2022.174998Test

مصطلحات موضوعية: Inflammation/chemically induced, Methotrexate/therapeutic use, Sulfasalazine/therapeutic use, Interleukin-1beta, Antibodies, Monoclonal, Humanized, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Etanercept, Immunomodulating Agents, Animals, Humans, Immunosuppression Therapy, Inflammation, Pharmacology, Diabetes Mellitus, Type 2/complications, Etanercept/pharmacology, Sulfasalazine, Interleukin 1 Receptor Antagonist Protein, Methotrexate, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Hydroxychloroquine/therapeutic use, Cardiovascular Diseases/drug therapy, Colchicine, Immunosuppressive Agents, Hydroxychloroquine, Interleukin-1

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f756fa0c7d520da4cd8a98288ea820dTest
http://hdl.handle.net/10651/65535Test

المؤلفون: Almer, Sven

المصدر: Gastrokuriren. 17(5):21

المساهمون: College of Medicine, Dept. of Internal Medicine, Yoon Suk Jung, Jae Hee Cheon, Soo Jung Park, Sung Pil Hong, Tae Il Kim, Won Ho Kim, Kim, Won Ho, Kim, Tae Il, Park, Soo Jung, Cheon, Jae Hee, Hong, Sung Pil

مصطلحات موضوعية: Adrenal Cortex Hormones/therapeutic use, Adult, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use, Behcet Syndrome/drug therapy, Behcet Syndrome/mortality, Behcet Syndrome/surgery, Disease Progression, Female, Follow-Up Studies, Gastrointestinal Agents/therapeutic use, Humans, Intestinal Diseases/mortality, Male, Mesalamine/therapeutic use, Middle Aged, Multivariate Analysis, Predictive Value of Tests, Prognosis, Recurrence, Remission Induction, Risk Factors, Severity of Illness Index, Sulfasalazine/therapeutic use

العلاقة: DIGESTIVE DISEASES AND SCIENCES; J00737; OAK-2013-03436; https://ir.ymlib.yonsei.ac.kr/handle/22282913/158485Test; https://link.springer.com/article/10.1007%2Fs10620-012-2351-9Test; T201306216; DIGESTIVE DISEASES AND SCIENCES, Vol.58(2) : 496-503, 2013

الإتاحة: https://doi.org/10.1007/s10620-012-2351-9Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/158485Test

المساهمون: Jung, Yoon Suk, Hong, Sung Pil, Kim, Tae Il, Kim, Won Ho, Cheon, Jae Hee

مصطلحات موضوعية: Adult, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use, Behcet Syndrome/drug therapy, Behcet Syndrome/prevention & control, C-Reactive Protein/analysis, Female, Humans, Intestinal Diseases/drug therapy, Intestinal Diseases/prevention & control, Male, Mesalamine/therapeutic use, Middle Aged, Predictive Value of Tests, Prognosis, Proportional Hazards Models, Secondary Prevention, Sulfasalazine/therapeutic use, Time Factors, Treatment Outcome, intestinal Behcet disease, 5-aminosalicylic acid, sulfa-salazine, clinical relapse

وصف الملف: e38~e45

العلاقة: JOURNAL OF CLINICAL GASTROENTEROLOGY; J01319; OAK-2012-00610; https://ir.ymlib.yonsei.ac.kr/handle/22282913/90683Test; http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00004836-201205000-00002&LSLINK=80&D=ovftTest; T201201040; JOURNAL OF CLINICAL GASTROENTEROLOGY, Vol.46(5) : 38-45, 2012

الإتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/90683Test
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00004836-201205000-00002&LSLINK=80&D=ovftTest

المساهمون: HYUN JUNG LEE, EUN SUK JUNG, JIN HA LEE, SUNG PIL HONG, TAE IL KIM, WON HO KIM, JAE HEE CHEON, Kim, Won Ho, Kim, Tae Il, Lee, Hyun Jung, Jung, Eun Suk, Cheon, Jae Hee, Hong, Sung Pil

مصطلحات موضوعية: Adolescent, Adult, Aged, 80 and over, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use, Colitis, Ulcerative/blood, Ulcerative/drug therapy, Ulcerative/pathology, Female, Hemoglobins, Humans, Maintenance Chemotherapy, Male, Mesalamine/therapeutic use, Middle Aged, Multivariate Analysis, Proportional Hazards Models, Recurrence, Republic of Korea, Retrospective Studies, Risk Factors, Severity of Illness Index, Sulfasalazine/therapeutic use, Time Factors, Treatment Outcome, Young Adult

العلاقة: HEPATO-GASTROENTEROLOGY; J00984; OAK-2012-00721; https://ir.ymlib.yonsei.ac.kr/handle/22282913/90349Test; http://cat.inist.fr/?aModele=afficheN&cpsidt=26196087Test; T201201553; HEPATO-GASTROENTEROLOGY, Vol.59(117) : 1415-1420, 2012

الإتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/90349Test
http://cat.inist.fr/?aModele=afficheN&cpsidt=26196087Test

المؤلفون: Haar, D, Svendsen, P, Helin, P

المصدر: Ugeskrift for Laeger. 160(21):3082